Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

European Commission funds EBI to do new research on synergies between bioinformatics and medical informatics

13.09.2005


The European Commission has selected the EBI to coordinate a project that will stimulate and explore synergies between bioinformatics (the science of storing, retrieving and analysing large amounts of biological information) and medical informatics (the science of processing, sharing and using large amounts of medical information). The SYMBiomatics project will culminate in a White Paper that will inform the Commission’s funding policy on the synergy between these two rapidly growing areas. The aim is to facilitate and accelerate biomedical research and innovation, with the ultimate goal of improving Europe’s efficiency at developing better tools and systems for disease prevention, diagnosis and treatment.



Building on decades of advances in deciphering the molecular components of living things, molecular and computational biologists are now synthesising the information that they’ve gathered, and are building a detailed understanding of cells, tissues, organs, organisms and populations. At the same time, clinical research has led to a better appreciation of the molecular basis of disease. Clinical scientists are amassing information that is helping them to decipher how variations in people’s genetic make-up can affect their likelihood of developing certain diseases such as cardiovascular disease or diabetes, or of developing an adverse response to particular drugs, such as the anti-coagulants used to treat some types of heart disease.

“The emerging discipline of biomedical informatics sits at the interface of the previously disparate worlds of bioinformatics and medical informatics,” says Graham Cameron, the EBI’s Associate Director and coordinator of the SYMBiomatics project. “The development of technologies that will allow scientific and clinical information to be shared and integrated more readily will expedite the creation of novel diagnostic, preventive and therapeutic methods, allowing people to lead longer, healthier lives.”


“It’s critical that the two fields of bioinformatics and medical informatics work together cooperatively to solve many common and complex problems,” says Gérard Comyn, Acting Director of the General Directorate Information Society and Media of the European Commission. “We predict that in the very near future these two previously separate disciplines will share vast amounts of information that will result in a massive improvement of the quality of life for European citizens.”

Working together over the next fifteen months, an executive committee comprising nine organisations from six different European Member States (UK, France, Italy, Spain, Greece and the Netherlands) will document the state of the art in biomedical informatics. The group will identify areas of maximum opportunity, by systematically collecting insights from experts in the field and by analysing the scientific literature. Areas of opportunity will then be documented and prioritised. The group’s findings will be presented at a meeting in early summer 2006, enabling further discussion by the wider community of bioinformaticians, medical informaticians, the growing number of clinical professionals whose work spans these domains and European policy makers. The project will culminate in a report that will summarise the project’s findings and will provide input to future European scientific and funding policy.

“Because there are many potential synergies between bioinformatics and medical informatics, it’s important to document and prioritise them so that we can identify the fastest route towards a healthier Europe,” explains Ilias Iakovidis, Deputy Head of the European Commission’s ICT for Health Unit.

Sarah Sherwood | alfa
Further information:
http://www.embl.org/aboutus/news/press/2005/press12sep05.html

More articles from Health and Medicine:

nachricht Why might reading make myopic?
18.07.2018 | Universitätsklinikum Tübingen

nachricht Unique brain 'fingerprint' can predict drug effectiveness
11.07.2018 | McGill University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

Lying in a foreign language is easier

19.07.2018 | Social Sciences

NYSCF researchers develop novel bioengineering technique for personalized bone grafts

18.07.2018 | Life Sciences

Machine-learning predicted a superhard and high-energy-density tungsten nitride

18.07.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>